[144] Argan, Inc SEC Filing

Rhea-AI Filing Summary

Argan, Inc. (AGX) – Form 144 insider sale notice

Insider John R. Jeffrey, Jr. has filed to sell up to 2,621 common shares through Charles Schwab on or about 29 Jul 2025. The proposed sale equals roughly 0.02 % of the 13.64 m shares outstanding and carries an aggregate market value of $623,798, implying a per-share price near $238.

The shares derive from two recent equity grants: a time-based restricted stock issuance of 390 shares on 13 Jun 2025 and an option-exercise grant of 7,731 shares on 17 Jan 2025. Over the past three months the same insider sold 5,500 shares on 9 Jun 2025 for gross proceeds of $1.20 m. The filer certifies awareness of no undisclosed adverse information and affirms compliance with Rule 144. No operational, earnings or guidance data are included in this filing.

Positive

• None.

Negative

• Insider selling—aggregate 8,121 shares over two months—can be perceived as a bearish sentiment indicator, albeit modest in scale.

Insights

Financial Analyst

TL;DR: Small Rule 144 sale (~0.02 % float) looks immaterial; neutral signal for AGX.

The filing discloses a planned disposition of 2,621 AGX shares worth roughly $0.6 m by insider John R. Jeffrey, Jr. The amount represents a de-minimis slice of the company’s 13.6 m outstanding shares and follows a 5,500-share sale in June. While insider selling can raise concern, the scale here is modest and appears tied to routine equity compensation. There is no indication of negative non-public information, and the seller attests to that under Rule 144. Absent complementary operational data, the event should be viewed as neutral for valuation and liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. Inc. 3000 Schwab Way Westlake TX 76262	2621	623798	13640813	07/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/13/2025	TIME-BASED RESTRICTED STOCK ISSUANCE	ISSUER			390	06/13/2025	N/A
Common Stock	01/17/2025	EQUITY GRANT	ISSUER			7731	01/17/2025	OPTION EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Boulevard, Suite 440 Arlington VA 22203	Common Stock	06/09/2025	5500	1197845

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Argan (AGX) shares does the insider plan to sell?

2,621 common shares are listed for sale under the Form 144 filing.

What is the approximate market value of the shares to be sold?

The filing states an aggregate market value of $623,798 for the 2,621 shares.

When is the planned sale date for the AGX shares?

The approximate sale date disclosed is 29 July 2025.

What percentage of Argan’s outstanding shares does the sale represent?

Roughly 0.02 % of the 13.64 million shares outstanding.

How were the shares being sold originally acquired?

Via restricted stock issuance (390 sh, 13 Jun 2025) and an option exercise (7,731 sh, 17 Jan 2025).

Has the insider sold AGX shares recently?

Yes, 5,500 shares were sold on 9 Jun 2025 for gross proceeds of $1.20 million.